A Simple Key For CFSE Unveiled
A phase I review in Japanese sufferers with R/R NHL, like ATLL patients, confirmed a manageable protection profile, and 40 mg two times every week was selected for subsequent scientific advancement.In summary, whilst the clinical effect of tucidinostat to the cure of PTCL has become elucidated, more mechanistic research and biomarker identificati